|
@ |
|
|
|
@ |
|
@ |
@ |
|||
|
@ |
•½¬‚Q‚O”N“xŠˆ“®Ž‘‹àŠñ•tŠé‹Æ ‹y‚Ñ Šñ•t‹¦—ÍŽÒ i•½¬‚Q‚O”N‚P‚QŒŽŒ»Ýj
œ@ƒAƒXƒgƒ‰ƒ[ƒlƒJДޮ‰ïŽÐ
@ œ@Îì@”ü’qŽq
œ@ƒG[ƒUƒCДޮ‰ïŽÐ
œ@ˆÇ—Ñ»–òДޮ‰ïŽÐ
œ@¬–ì–ò•iH‹ÆŠ”Ž®‰ïŽÐ
œ@Glaxo-SmithKlineДޮ‰ïŽÐ
œ@Дޮ‰ïŽÐ‹¦˜aŠé‰æ
œ@Дޮ‰ïŽÐƒ|[ƒ‰ƒtƒ@[ƒ}
œ@’è‰i@‹±–¾
œ@ƒTƒmƒtƒBEƒAƒ”ƒFƒ“ƒeƒBƒXДޮ‰ïŽÐ
œ@‘å“ú–{Z—F»–òДޮ‰ïŽÐ
œ@äÝ—L»–òДޮ‰ïŽÐ
œ@“c•ÓŽO•H»–òДޮ‰ïŽÐ
œ@‹¦˜a”yƒLƒŠƒ“Дޮ‰ïŽÐ
•½¬‚P‚X”N“xŠˆ“®Ž‘‹àŠñ•tŠé‹Æ
œ@ƒAƒXƒgƒ‰ƒ[ƒlƒJДޮ‰ïŽÐ
@ œ@Glaxo-SmithKlineДޮ‰ïŽÐ
œ@‘å’Ë»–òДޮ‰ïŽÐ
œ@¬–ì–ò•iH‹ÆŠ”Ž®‰ïŽÐ
œ@Дޮ‰ïŽÐ‹¦˜aŠé‰æ
œ@ƒVƒFƒŠƒ“ƒOEƒvƒ‰ƒEДޮ‰ïŽÐ
œ@ƒLƒbƒZƒC–ò•iH‹ÆŠ”Ž®‰ïŽÐ
œ@ˆÇ—Ñ»–òДޮ‰ïŽÐ
œ@‹¦˜a”yH‹ÆŠ”Ž®‰ïŽÐ
œ@’élƒtƒ@[ƒ}Дޮ‰ïŽÐ
œ@‘å“ú–{Z—F»–òДޮ‰ïŽÐ
œ@ƒmƒoƒ‹ƒeƒBƒXƒtƒ@[ƒ}Дޮ‰ïŽÐ@
•½¬‚P‚W”N“xŠˆ“®Ž‘‹àŠñ•tŠé‹Æ
œ@ƒAƒXƒgƒ‰ƒ[ƒlƒJДޮ‰ïŽÐ
@ œ@ƒmƒoƒ‹ƒeƒBƒXƒtƒ@[ƒ}Дޮ‰ïŽÐ@
œ@ƒG[ƒUƒCДޮ‰ïŽÐ
œ@¬–ì–ò•iH‹ÆŠ”Ž®‰ïŽÐ
œ@Дޮ‰ïŽÐ‹¦˜aŠé‰æ
œ@ƒLƒbƒZƒC–ò•iH‹ÆŠ”Ž®‰ïŽÐ
œ@Glaxo-SmithKlineДޮ‰ïŽÐ
œ@ˆÇ—Ñ»–òДޮ‰ïŽÐ
œ@‹¦˜a”yH‹ÆŠ”Ž®‰ïŽÐ
œ@ƒVƒFƒŠƒ“ƒOEƒvƒ‰ƒEiŠ”j
œ@‘峕xŽRˆã–ò•iДޮ‰ïŽÐ
œ@‘å“ú–{Z—F»–òДޮ‰ïŽÐ
œ@’élƒtƒ@[ƒ}Дޮ‰ïŽÐ
œ@–¾Ž¡»‰ÙДޮ‰ïŽÐ